Oral formulations of cytidine analogs and methods of use thereof
US8846628B2 · kind B2 · utility
10Cited by
22References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2009 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Jan 29, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pharmaceutical compositions comprising cytidine analogs, for example, 5-azacytidine or decitabine, for oral administration, wherein the compositions release the cytidine analog, for example, 5-azacytidine or decitabine, substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.